Westfield Capital Management
TECH icon

Westfield Capital Management’s Bio-Techne TECH Stock Holding History

Westfield Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-856,043
Closed -$44.7M – 314
2026
Q1 		$44.7M Sell
856,043
-138,287
-14% -$8.3M 0.19% 152
2025
Q4 		$58.5M Buy
+994,330
New +$60.4M 0.24% 136
2025
Q3 		– Sell
-9,570
Closed -$492K – 274
2025
Q2 		$492K Sell
9,570
-666,838
-99% -$33.5M ﹤0.01% 233
2025
Q1 		$39.7M Buy
+676,408
New +$45.8M 0.19% 148
2023
Q4 		– Sell
-699,662
Closed -$47.6M – 265
2023
Q3 		$47.6M Buy
699,662
+92,521
+15% +$7.31M 0.32% 121
2023
Q2 		$49.6M Buy
+607,141
New +$48.8M 0.31% 120

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Westfield Capital Management's TECH Position: Q2 2026 in Review

Westfield Capital Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 856,043 shares — an estimated $44.7M sold.

Westfield Capital Management first reported a position in TECH in Q2 2023 and held it in 6 quarters. The position peaked at $58.5M in Q4 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Westfield Capital Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Westfield Capital Management sold 856,043 Bio-Techne shares in Q2 2026, an estimated $44.7M.
  • Westfield Capital Management first reported a position in Bio-Techne in Q2 2023 and held it in 6 quarters.
  • Westfield Capital Management's Bio-Techne position peaked at $58.5M in Q4 2025.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Westfield Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.